increased glutathione in acute myeloid leukemia Metabolic reprogramming and immune regulation Targeting Aberrant Glutathione Metabolism to
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells ScienceDirect Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response Leukemia Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia Cell Death Discovery Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



